IL-6 has been reported to be the leading cause of inflammatory response in severe COVID-19 and emerged as an important regulator of Th1/Th2 differentiation, promoting the IL-4-dependent induction of Th2 differentiation and inhibiting Th1 differentiation [42,43]. This evidence concerns the gene IL4 and COVID-19.